What is the recommended evaluation and management for an adult with episodic migraine (fewer than 15 headache days per month) and no contraindications?

Status Migrainosus: Evaluation and Management

For status migrainosus—a severe, continuous migraine lasting more than 72 hours—initiate intravenous corticosteroids as first-line therapy, combined with IV antiemetics and hydration, reserving parenteral NSAIDs and triptans for refractory cases. 1

Definition and Initial Assessment

Status migrainosus is defined as a debilitating migraine attack persisting beyond 72 hours, representing a medical urgency distinct from chronic migraine (which requires ≥15 headache days per month for >3 months). 1, 2

Key diagnostic features to confirm:

• Continuous headache exceeding 72 hours despite treatment 1
• Maintains typical migraine characteristics: unilateral, pulsating, moderate-to-severe intensity 2
• Associated symptoms: nausea/vomiting, photophobia, phonophobia 2
• Rule out secondary causes through focused history (no "red flags" such as sudden onset, focal deficits, fever) 2

Treatment Algorithm

First-Line: IV Corticosteroids + Antiemetics + Hydration

Initiate immediately upon diagnosis:

• IV corticosteroids (dexamethasone 4-8 mg or equivalent) as the treatment of choice, though high-quality evidence is limited 1
• IV antiemetics (metoclopramide 10 mg or prochlorperazine 10 mg) to treat nausea and improve gastric motility, which is impaired during prolonged attacks 1
• IV hydration with normal saline to address dehydration from prolonged vomiting 1

This combination addresses the core pathophysiology and provides dual benefits: antiemetics offer both anti-nausea effects and direct analgesic properties. 1

Second-Line: Add Parenteral NSAIDs (1-2 Hours if Inadequate Response)

If pain persists after initial therapy:

• IV ketorolac 30 mg offers relatively rapid onset with 6-hour duration and minimal rebound headache risk 1
• This agent is preferred over oral NSAIDs due to impaired gastric absorption during status migrainosus 2

Third-Line: Migraine-Specific Agents for Refractory Cases

For patients not responding to above measures within 2-4 hours:

• Subcutaneous sumatriptan 6 mg when patients cannot tolerate oral medications or require rapid onset 1
• IV dihydroergotamine (DHE) as an alternative, but never within 24 hours of triptan use due to additive vasoconstrictive effects 1
• Verify no recent triptan use and no cardiovascular contraindications before administering 1

Fourth-Line: Adjunctive Therapy

For refractory cases:

• IV magnesium sulfate 1-2 grams as an effective adjunct in the emergency setting 1
• Opioid analgesics (meperidine) or butorphanol nasal spray only when other treatments fail, with careful monitoring for dependency and rebound headaches 1

Critical Management Principles

Non-oral routes are mandatory when significant nausea or vomiting is present, as gastric motility is severely impaired during prolonged migraine attacks. 1, 2

Avoid oral ergot alkaloids entirely—they are poorly effective and potentially toxic in this setting. 1

Monitor for medication overuse: If the patient has been using acute medications on ≥10 days per month (triptans, ergots, combination analgesics) or ≥15 days per month (simple analgesics), medication overuse may be perpetuating the status migrainosus. 2 Discontinuation is essential but may temporarily worsen symptoms. 1

Post-Acute Management

Once the acute episode resolves:

• Initiate or optimize preventive therapy immediately to prevent recurrence, as status migrainosus indicates inadequate migraine control 1
• Limit future acute medication use to no more than 2 days per week (10 days per month) to prevent medication-overuse headache 1
• Consider prophylactic agents: For episodic migraine, first-line options include propranolol (80-240 mg/d), timolol (20-30 mg/d), amitriptyline (30-150 mg/d), or divalproex sodium (500-1500 mg/d) 2

Special Populations

Cardiovascular disease: Avoid triptans and DHE; use NSAIDs or antiemetics as primary therapy. 1

Pregnancy: Acetaminophen and antiemetics are preferred; avoid NSAIDs (especially third trimester) and triptans. 1

Common Pitfalls

Narcotic overreliance: Opioids lead to dependency, rebound headaches, and eventual loss of efficacy—reserve for truly refractory cases only. 1

Premature discharge: Status migrainosus requires observation until sustained improvement is documented, as relapse within 24-48 hours is common. 3

Ignoring medication overuse: Failing to address overuse of acute medications perpetuates the cycle and prevents long-term improvement. 1, 2